SENSEONICS HLGS.INC.-001
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabet… Read more
SENSEONICS HLGS.INC.-001 (6L6) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SENSEONICS HLGS.INC.-001 (6L6) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SENSEONICS HLGS.INC.-001 - Net Assets Trend (None–None)
This chart illustrates how SENSEONICS HLGS.INC.-001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SENSEONICS HLGS.INC.-001 (None–None)
The table below shows the annual net assets of SENSEONICS HLGS.INC.-001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SENSEONICS HLGS.INC.-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SENSEONICS HLGS.INC.-001 Competitors by Market Cap
The table below lists competitors of SENSEONICS HLGS.INC.-001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Navarre Minerals Limited
PINK:NVMLF
|
$12.28 Million |
|
Nuclear Fuels Inc.
OTCQX:NFUNF
|
$12.29 Million |
|
MCT Bhd
KLSE:5182
|
$12.29 Million |
|
MUEHLHAN
HM:M4N
|
$12.29 Million |
|
Jackpot Digital Inc
OTCQB:JPOTF
|
$12.28 Million |
|
Enersense International Oyj
HE:ESENSE
|
$12.28 Million |
|
Yieh United Steel
TWO:9957
|
$12.28 Million |
|
Westward Gold Inc
OTCQB:WGLIF
|
$12.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SENSEONICS HLGS.INC.-001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SENSEONICS HLGS.INC.-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SENSEONICS HLGS.INC.-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SENSEONICS HLGS.INC.-001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SENSEONICS HLGS.INC.-001 (6L6) | €- | N/A | N/A | $12.28 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |